Principal Investigator: Dr. Richard Frye, MD, PhD

Professor of Neurology, Phoenix Children’s Hospital and Professor of Child Health, University of Arizona, Phoenix AZ

Transcranial Photobiomodulation in Autism Spectrum Disorder: A Double-Blind, Placebo Controlled, Randomized Clinical Study of a Novel Intervention


Principal Investigator: Dr. Richard Frye, MD, PhD

Professor of Neurology, Phoenix Children’s Hospital and Professor of Child Health, University of Arizona, Phoenix AZ

High- Frequency Oscillation as a Biomarker of Mitochondrial Dysfunction Associated with Epilepsy in Autism


Principal Investigator: Dr. Tolga Atilla Ceranoglu, MD

Assistant Professor in Psychiatry, Harvard Medical School – Massachusetts General Hospital

Transcranial Photobiomodulation in Autism Spectrum Disorder: A Double-Blind, Placebo Controlled, Randomized Clinical Study of a Novel Intervention


Principal Investigator: Dr. Paul Ashwood, PhD

Institutions: M.I.N.D. Institute, UC Davis Institute

Pilot Investigation of Epigenetic Mechanisms of Innate Immune Activation In Autism Spectrum Disorder


Principal Investigator: Dr. Harris Huberman, MD

Institutions: SUNY Downstate Medical Center University Hospital

Early Biomarkers In Autism Spectrum Disorder: Birth Folate Autoantibody Receptor Status


Principal Investigator: Dr. Alessio Fasano, MD

Chief of Pediatric Gastroenterology and Nutrition at Massachusetts General Hospital for Children (MGHfC)

A Humanized Mouse Model and Human Gut Organoids to Exploit the Zonulin Pathway for Personalized Treatment of Autism Spectrum Disorder


Principal Investigator: Jyonouchi Harumi, MD

Faculty, Department of Pediatrics
Clinical Professor of Pediatrics, Rutgers-RWJ, Saint Peter’s University Hospital 

Biomarkers of Innate Immune Memory in Autism Spectrum Disorders


Principal Investigator: Dr. Stuart Lipton, MD, PhD

Professor, Co-director, Neuroscience Translational Center, Department of Molecular Medicine, Scripps Research

MEF2C Haploinsufficiency Drug Discovery


Principal Investigator: Dr. Joseph Buxbaum, PhD

Molecular and Cellular Neuroscientist, Director of the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai

Connecting Rare Genetic Mutations in Autism to Common Biological Pathways


Principal Investigator: Dr. Randy Blakely, PhD

Executive Director, FAU Brain Institute
Professor of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University

Pharmacologically Remediable Traits of ASD in a Mouse Model Implicate a Seratonin – Neuroinflammatory Connection


Principal Investigator: Edward V Quadros, PhD

Department of Medicine, College of Medicine
SUNY Downstate Medical Center, NY

Establish a Rat Model of ASD to Study Genetic and Epigenetic Changes, their Generational Transmission and Associated Behavioral Deficits.


Principal Investigator: Dr. Arthur Krigsman, MD & Dr. Stephen Walker, PhD

Autism GI (Private Practice) & Wake Forest Institute

Study the Pathological Status in Gastrointestinal Tissue Procured from GI Symptomatic Children With and Without ASD


Principal Investigator: Dr. Juergen Hahn

Head of the Department of Biomedical Engineering at Rensselaer Polytechnic Institute

Using AI & Machine Learning to Develop Metabolic Biomarkers in Autism Spectrum Disorders


Principal Investigator: Dr. James Adams, PhD

Institutions: Arizona State University, Wake Forest Institute and UC Davis Mind Institute

MTT(Microbiota Transfer Therapy) for individuals with autism, with Extensive Testing 


Principal Investigator: Sarkis Mazmanian, PhD

Luis & Nelly Soux Professor of Microbiology Investigator, Heritage Medical Research Institute Division of Biology and Biological Engineering, California Institute of Technology

Exploring the Contribution of the Gut Microbiome in an Established Mouse Model of ASD to Identify Changes in Neurotransmitter Release, Immune Responses, and GI Function


Principal Investigator: Dr. Paul Ashwood, PhD

Institutions: M.I.N.D. Institute, UC Davis Institute

Understanding Differences in Intestinal Epithelium in Autism and Controls, and Constructing a Biobank of Intestinal Organoids